These opportunities are not managed nor endorsed by RCPCH. Though we do our best to ensure they are relevant and high quality, we cannot take any responsibility for their content or accuracy. If you have questions or would like to submit a joint funding application with the College, contact us on firstname.lastname@example.org.
Supports the development of cardiovascular technologies from the proof-of-concept stage to being ready for the commercial market. Designed to help to bridge the funding gap between promising innovations and the clinic with the aim of accelerating advances for patient benefit.
Funds highly ambitious translational research conducted in association with a clinical trial or well designed clinical study.The types of studies that fit this scheme are typically investigator-led studies for highly ambitious translational research conducted in association with a clinical trial or well-designed clinical study with the objective of optimising treatment and maximising patient benefit.
Fund Strategic Research Centres intended to create multidisciplinary teams to address questions of strategic relevance to people with cystic fibrosis.
The RD Lawrence Fellowship is a career development fellowship that enables postdoctoral researchers to establish their independence in diabetes research.
Provides funding to enable research teams to undertake social sciences research - anything from a standard research project through to a large scale survey or methodological development.
Allows exceptional established research leaders to pursue groundbreaking, high risk projects that open new directions in their respective research fields or other domains.
Supports researchers at the stage at which they are consolidating their own independent research team or programme.
Aims to support up and coming research leaders who are about to establish a proper research team and to start conducting independent research in Europe. It will support the creation of excellent new research teams.
Supports audit programmes to improve quality of service and outcomes.
Supports translational rare disease research projects. Focus will be on developing an intervention (therapeutic, device or diagnostic) that will address a significant, unaddressed need for rare disease patients and on research which has a credible translational and development path to reaching patients.